Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 8 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 19 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 1, subfamily A, polypeptide 2 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 9 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 3, subfamily A, polypeptide 4 | Starlite/ChEMBL | References |
Homo sapiens | protein tyrosine kinase 2 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 2, subfamily D, polypeptide 6 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 490 aa | 441 aa | 21.8 % |
Leishmania major | cytochrome p450-like protein | cytochrome P450, family 2, subfamily C, polypeptide 19 | 490 aa | 411 aa | 23.1 % |
Brugia malayi | cytochrome P450 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 502 aa | 492 aa | 24.2 % |
Brugia malayi | cytochrome P450 | cytochrome P450, family 2, subfamily D, polypeptide 6 | 497 aa | 425 aa | 32.0 % |
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 490 aa | 435 aa | 22.3 % |
Brugia malayi | Cytochrome P450 family protein | cytochrome P450, family 1, subfamily A, polypeptide 2 | 516 aa | 470 aa | 26.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | protein tyrosine kinase | 0.0305 | 0.1752 | 0.118 |
Echinococcus granulosus | protein tyrosine kinase | 0.0305 | 0.1752 | 0.118 |
Brugia malayi | Regulator of G protein signaling domain containing protein | 0.0157 | 0.0785 | 0.0785 |
Loa Loa (eye worm) | AGC/GRK/GRK protein kinase | 0.1572 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0157 | 0.0785 | 0.5 |
Trypanosoma brucei | cytochrome P450, putative | 0.0036 | 0 | 0.5 |
Loa Loa (eye worm) | AGC/GRK/BARK protein kinase | 0.0161 | 0.081 | 0.081 |
Loa Loa (eye worm) | AGC/GRK/GRK protein kinase | 0.1415 | 0.8979 | 0.8979 |
Brugia malayi | Regulator of G protein signaling domain containing protein | 0.0157 | 0.0785 | 0.0785 |
Echinococcus multilocularis | G protein coupled receptor kinase 6 | 0.1415 | 0.8979 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0157 | 0.0785 | 0.0785 |
Schistosoma mansoni | serine/threonine protein kinase | 0.1572 | 1 | 1 |
Echinococcus granulosus | [G-protein-coupledreceptor] kinase | 0.1415 | 0.8979 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0095 | 0.0381 | 0.0381 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0036 | 0 | 0.5 |
Brugia malayi | regulator of G-protein signaling egl-10 | 0.0157 | 0.0785 | 0.0785 |
Loa Loa (eye worm) | hypothetical protein | 0.0157 | 0.0785 | 0.0785 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0036 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0157 | 0.0785 | 0.5 |
Loa Loa (eye worm) | PXA domain-containing protein | 0.0157 | 0.0785 | 0.0785 |
Loa Loa (eye worm) | G protein-coupled receptor kinase 1 | 0.1415 | 0.8979 | 0.8979 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0157 | 0.0785 | 0.5 |
Loa Loa (eye worm) | RGS-3 protein | 0.0157 | 0.0785 | 0.0785 |
Brugia malayi | hypothetical protein | 0.0157 | 0.0785 | 0.0785 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0036 | 0 | 0.5 |
Brugia malayi | Probable G protein-coupled receptor kinase F19C6.1, putative | 0.1415 | 0.8979 | 0.8979 |
Brugia malayi | PXA domain containing protein | 0.0157 | 0.0785 | 0.0785 |
Trichomonas vaginalis | regulator of G protein signaling 5, rgs5, putative | 0.0157 | 0.0785 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0161 | 0.081 | 0.0027 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0161 | 0.081 | 0.0027 |
Loa Loa (eye worm) | hypothetical protein | 0.0157 | 0.0785 | 0.0785 |
Echinococcus multilocularis | beta adrenergic receptor kinase | 0.0161 | 0.081 | 0.003 |
Loa Loa (eye worm) | TK/FAK protein kinase | 0.0309 | 0.1775 | 0.1775 |
Loa Loa (eye worm) | hypothetical protein | 0.0157 | 0.0785 | 0.0785 |
Leishmania major | cytochrome p450-like protein | 0.0036 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0157 | 0.0785 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0157 | 0.0785 | 0.5 |
Loa Loa (eye worm) | G protein signaling regulator EGL-10 | 0.0157 | 0.0785 | 0.0785 |
Echinococcus granulosus | beta-adrenergic receptor kinase | 0.0161 | 0.081 | 0.003 |
Brugia malayi | PXA domain containing protein | 0.0157 | 0.0785 | 0.0785 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0095 | 0.0381 | 0.0381 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0157 | 0.0785 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0305 | 0.1752 | 0.1049 |
Brugia malayi | A-kinase anchor protein 10, precursor | 0.0157 | 0.0785 | 0.0785 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0157 | 0.0785 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0157 | 0.0785 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0309 | 0.1775 | 0.1775 |
Loa Loa (eye worm) | hypothetical protein | 0.0157 | 0.0785 | 0.0785 |
Brugia malayi | regulator of G-protein signaling rgs-7 | 0.0157 | 0.0785 | 0.0785 |
Loa Loa (eye worm) | hypothetical protein | 0.0157 | 0.0785 | 0.0785 |
Entamoeba histolytica | hypothetical protein | 0.0157 | 0.0785 | 0.5 |
Brugia malayi | hypothetical protein | 0.0157 | 0.0785 | 0.0785 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Fu (ADMET) | = 0.3 % | Fraction unbound in mouse serum | ChEMBL. | 23973211 |
Fu (ADMET) | = 0.35 % | Fraction unbound in human serum | ChEMBL. | 23973211 |
IC50 (ADMET) | = 4.8 uM | Inhibition of CYP2D6 (unknown origin) | ChEMBL. | 23973211 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP3A4 (unknown origin) | ChEMBL. | 23973211 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP2C19 (unknown origin) | ChEMBL. | 23973211 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP2C9 (unknown origin) | ChEMBL. | 23973211 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP2C8 (unknown origin) | ChEMBL. | 23973211 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP1A2 (unknown origin) | ChEMBL. | 23973211 |
IC50 (binding) | > 10 uM | Inhibition of FAK (unknown origin) using biotinylated-His-TEVhsFAK(31-686)(K454R) as substrate after 2 hrs by scintillation counting analysis | ChEMBL. | 23973211 |
Kd (binding) | = 4 uM | Binding affinity to FAK kinase (unknown origin) by surface plasmon resonance assay | ChEMBL. | 23973211 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.